Fanconi Anemia: Fanconi anemia, breast and embryonal cancer risk revisited
- 16 May 2007
- journal article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 15 (7) , 715-717
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancerNature Genetics, 2006
- Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility allelesNature Genetics, 2006
- Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2Molecular Cell, 2006
- Molecular pathogenesis of Fanconi anemia: recent progressBlood, 2006
- Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJCancer Cell, 2005
- Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in ChromatinMolecular and Cellular Biology, 2004
- Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhoodBlood, 2004
- Biallelic Inactivation of BRCA2 in Fanconi AnemiaScience, 2002